查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018755

PTA球囊导管市场：2026-2032年全球市场预测（依产品类型、球囊材料、应用、最终用户和销售管道划分）

PTA Balloon Catheter Market by Product Type, Balloon Material, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

PTA球囊导管市场预计到2025年将达到32.3亿美元，到2026年将成长到34.7亿美元，到2032年将达到52.3亿美元，复合年增长率为7.09%。

主要市场统计数据
基准年 2025 32.3亿美元
预计年份：2026年 34.7亿美元
预测年份 2032 52.3亿美元
复合年增长率 (%) 7.09%

对经皮血管成形术 (PTA) 球囊技术、临床应用案例以及影响采用和采购决策的相关人员决策因素进行全面概述。

本篇摘要将说明现代经皮经皮血管成形术（PTA）球囊导管的临床应用、器械发展演变以及相关人员趋势。从临床需求出发，PTA 仍然是恢復冠状动脉、神经血管和周边血管解剖结构通畅性性的基石治疗方法，而器械的创新不断改变手术成功与长期血管健康之间的平衡。同时，临床医师和采购团队在选择器械时，不仅考虑其即时输送和扩张特性，还会考虑药物涂层和精准切割技术带来的长期治疗效果。

临床证据、材料技术的进步和不断发展的医疗保健服务模式的整合如何从根本上改变 PTA 球囊的设备选择、采购和临床路径。

经皮腔内血管成形术（PTA）球囊导管领域正经历着一场变革，这主要得益于临床证据的积累、材料科学的进步以及治疗输送模式的改变，所有这些因素共同作用，旨在改善手术效果。在临床方面，真实世界数据（REW）的累积和影像技术的进步提高了病变评估和器械选择的准确性，使临床医生能够根据病变形态选择合适的球囊类型，而不再仅仅依赖传统方案。同时，高性能尼龙、聚对苯二甲酸乙二醇酯（PET）结构和先进聚氨酯等材料的创新拓展了可实现的充气压力和外形优化范围，从而在顺应性和径向强度之间形成了新的权衡。

评估累积关税调整和贸易政策变化如何推动球囊导管製造业的结构重组、在地化和韧性策略。

关税环境和国际贸易措施是医疗设备全球供应链规划的关键因素，而近期政策调整进一步加剧了球囊导管组件和成品采购决策的复杂性。关税波动会影响各製造区域的相对竞争力，影响垂直整合生产和外部采购组件的选择，并改变区域进口成本。这些趋势迫使製造商重新评估其多供应商策略，并提高对关键原材料（例如特殊聚合物和涂料化学品）的层级供应商关係的透明度。

将产品分类、解剖应用、最终用户环境、材料选择和分销管道与策略商业性定位联繫起来的多方面细分洞察。

深入的細項分析揭示了产品、应用、终端用户、材料和销售管道这五个维度如何共同决定球囊导管相关人员的商业性和临床策略。从产品角度来看，传统球囊、切割球囊和药物涂层球囊分别满足不同的手术需求。在传统球囊中，顺应性、非顺应性和半相容这三种分类会影响临床医师基于病变顺应性和所需血管支架的偏好。另一方面，药物涂层球囊的临床定位则取决于所使用的药物是紫杉醇还是Sirolimus，以及涂层在充气过程中的释放方式。

清晰的区域洞察，区分美洲、欧洲、中东和非洲市场以及亚太地区的商业性方法，优化部署、兑换和供应策略。

区域趋势正在形成多样化的需求模式和监管环境，这对商业化和临床导入策略产生重大影响。在美洲，先进的心臟导管介入基础设施和广泛的三级医疗中心覆盖推动了手术量的成长和分阶段器械创新技术的早期应用，同时，报销框架和区域供应链能力也影响着采购行为。欧洲、中东和非洲（EMEA）地区则呈现显着的异质性。虽然西欧市场通常强调循证应用和严格的采购竞标，全部区域EMEA新兴市场则优先考虑成本效益和可扩展的库存模式，从而导致了不同的市场进入策略。

创新驱动型公司如何平衡研发、临床证据的创造和生产柔软性，以确保竞争优势和持续的临床应用？

PTA球囊导管领域的主要企业正致力于结合针对性的研发投资、策略伙伴关係和灵活的生产製造能力，以保持差异化优势。许多企业正在将资源重新分配到材料科学和涂层技术方面，以改善导管的输送性能和生物相容性；而另一些企业则优先透过研究者主导的临床研究和参与註册登记来积累临床证据，从而支持其关于导管耐用性和安全性的声明。与医院系统和关键意见领袖（KOL）的合作仍然是检验导管在复杂解剖结构中的性能以及产生真实世界数据（REW）的核心策略，以支援导管在急诊和门诊环境中的应用。

为医疗设备製造商提供切实有效的建议，使其产品策略、证据产生和供应链韧性与其独特的临床和商业性现实相适应。

产业领导者应采取一系列切实可行的倡议，以增强自身竞争优势并加速临床应用。首先，他们应将产品开发蓝图与特定治疗领域相匹配，透过结合不同的材料和涂层方案来应对特定的病变类型，从而减少器械选择的临床不确定性。其次，他们应投资于切实可行的临床证据项目，利用註册研究和真实世界数据来补充随机试验，以证明产品在不同患者群体和医疗环境中的价值。第三，他们应采取地域均衡的供应策略，将区域性生产与关键材料的多通路采购结合，以降低关税和物流风险，同时维持品管。

高度透明的混合方法研究设计，结合了第二手资料的整合和专家的一手检验，确保了研究结果的严谨性和可重复性，以及明确的局限性。

本研究采用综合调查方法，结合结构化的二手资料和一手质性检验，建构了稳健且可重复的证据基础。二手资料分析整合了同行评审的临床文献、监管申报文件、材料科学出版物和操作指南，对医疗设备的分类、应用案例和已知的安全注意事项进行了梳理。在此基础上，一手研究对介入医师、采购负责人和医疗设备研发经理进行了半结构式访谈，以检验市场动态，深入探究推广应用的障碍，并揭示不同医疗机构间细微的操作差异。

这一结论将医疗设备创新、临床策略和营运韧性联繫起来，并将它们整合为可操作的挑战，以实现可持续的临床部署和商业性成功。

总之，PTA球囊导管领域正处于一个转折点，临床细微差别、材料创新和供应链策略在此交汇融合，为器械製造商、临床医生和支付方创造了差异化的机会。医疗设备的选择越来越注重病灶特异性和实证医学，迫使企业调整产品设计以适应明确的应用场景，同时维持强而有力的上市后监测。贸易政策的波动和关税调整进一步增加了营运的复杂性，促使企业更加重视在地化生产和灵活的筹资策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：PTA球囊导管市场：依产品类型划分

  • 传统球囊
    • 合规
    • 不合规
    • 半相容
  • 切割球囊
  • 药物涂层气球
    • 紫杉醇涂层
    • Sirolimus涂层

第九章：PTA球囊导管市场（依球囊材质划分）

  • 尼龙
  • PET
  • 聚氨酯

第十章：PTA球囊导管市场：依应用领域划分

  • 冠状动脉成形术
    • 分支
    • 原冠状动脉
  • 神经血管成形术
    • 颅外
    • 颅内
  • 週边血管成形术
    • 股腘窝
    • 髂骨
    • 肾

第十一章 PTA球囊导管市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十二章：PTA球囊导管市场：依销售管道划分

  • 离线
  • 在线的

第十三章：PTA球囊导管市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 PTA球囊导管市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：PTA球囊导管市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国PTA球囊导管市场

第十七章：中国PTA球囊导管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Accura Medizintechnik GmbH
  • Andratec GmbH
  • AV Medical Technologies Ltd.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd
  • Cardinal Health, Inc.
  • Conic Vascular
  • Cook Medical Inc.
  • Freudenberg & Co. KG
  • Infinity Angioplasty Balloon Company
  • Koninklijke Philips NV
  • Leo Medical Co.,Ltd.
  • Medcaptain Medical Technology Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Nordson Corporation
  • NuMED
  • Poba Medical
  • Q3 Medical Devices Limited
  • QX Medical LLC
  • Ridgeback Technologies
  • Simeks Medical
  • Teleflex Incorporated
  • Terumo Medical Corporation
Product Code: MRR-A26E0E5741FA

The PTA Balloon Catheter Market was valued at USD 3.23 billion in 2025 and is projected to grow to USD 3.47 billion in 2026, with a CAGR of 7.09%, reaching USD 5.23 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.23 billion
Estimated Year [2026] USD 3.47 billion
Forecast Year [2032] USD 5.23 billion
CAGR (%) 7.09%

Comprehensive orientation to percutaneous transluminal angioplasty balloon technology, clinical use cases, and stakeholder decision drivers shaping adoption and procurement choices

This executive introduction orients readers to the clinical application, device evolution, and stakeholder dynamics that define the contemporary PTA balloon catheter environment. Beginning with the clinical imperative, percutaneous transluminal angioplasty remains a cornerstone intervention for restoring vessel patency across coronary, neurovascular, and peripheral anatomies, and device innovations have continuously shifted the balance between procedural success and long-term vessel health. In parallel, clinicians and procurement teams now weigh device selection not only on immediate deliverability and inflation characteristics but also on long-term outcomes influenced by pharmacologic coatings and precision cutting technologies.

Moving from practice patterns to product taxonomy, the market encompasses conventional balloons, cutting balloons, and drug coated balloons, each with material and compliance attributes that materially affect clinical handling. Conventional balloons are evaluated across compliant, non-compliant, and semi-compliant performance envelopes, while drug coated variants differ by antiproliferative agents such as paclitaxel and sirolimus. These technical distinctions intersect with setting of care choices, ranging from ambulatory surgical centers to high-acuity hospitals, and with procurement channels that now include both offline and online sales pathways. Taken together, the introduction frames a multi-stakeholder landscape where clinical evidence, device engineering, and distribution strategy interact to shape adoption dynamics.

How converging clinical evidence, material advances, and evolving care delivery models are fundamentally reshaping device selection, procurement, and clinical pathways for PTA balloons

The PTA balloon catheter landscape is undergoing transformative shifts driven by converging clinical evidence, material science advances, and changes in delivery models that collectively elevate procedural outcomes. On the clinical front, growing real-world evidence and refined imaging modalities have increased the precision of lesion assessment and device selection, prompting clinicians to choose balloon types aligned to lesion morphology rather than defaulting to legacy options. Meanwhile, material innovations such as high-performance nylons, polyethylene terephthalate constructs, and advanced polyurethanes have expanded the envelope of achievable inflation pressures and profile optimization, thereby enabling new trade-offs between trackability and radial strength.

Concurrently, drug coated technologies are being reevaluated with more granular attention to drug formulation, excipient systems, and coating transfer efficiency, fostering a move towards agent-specific clinical strategies. Distribution and procurement are also shifting, with online channels complementing traditional offline pathways and ambulatory settings gaining relevance for selected low-complexity procedures. Regulatory expectations and payer scrutiny have further incentivized manufacturers to align product development with clear endpoints and robust post-market evidence generation. As a result, industry actors who integrate clinical insight, material differentiation, and distribution agility are best positioned to capture the next wave of procedural demand.

Assessment of how cumulative tariff adjustments and trade policy changes are prompting structural supply chain reconfiguration, localization, and resilience strategies across balloon catheter manufacturing

Tariff environments and international trade measures have become material factors in planning global supply chains for medical devices, and recent policy adjustments have added complexity to sourcing decisions for balloon catheter components and finished products. Tariff shifts impact the relative competitiveness of manufacturing geographies, influence choices between vertically integrated production versus outsourced components, and alter landed costs across regions. Those dynamics compel manufacturers to reassess multi-sourcing strategies and to seek greater visibility into tiered supplier relationships for key inputs such as specialized polymers and coating chemistries.

In response, companies are accelerating localization efforts where feasible, optimizing inventory strategies, and renegotiating contractual frameworks to insulate against further trade policy volatility. Regulatory harmonization efforts and bilateral trade agreements can mitigate some cost pressures, but procurement teams increasingly adopt scenario planning to quantify exposure and to prioritize supply resilience over narrow cost optimization. For organizations that serve diverse regional markets, the cumulative effect of tariff changes has driven a more deliberate approach to production footprint, quality oversight, and logistics partnerships to ensure continuity of supply without compromising clinical standards.

Multi-dimensional segmentation insights linking product classes, anatomical applications, end-user settings, material choices, and distribution channels to strategic commercial positioning

Insightful segmentation analysis reveals how product, application, end user, material, and sales channel dimensions jointly define commercial and clinical strategies for balloon catheter stakeholders. From a product perspective, conventional balloons, cutting balloons, and drug coated balloons each address distinct procedural needs; within conventional devices, the compliant, non-compliant, and semi-compliant classifications drive clinician preference based on lesion compliance and required vessel scaffolding, whereas drug coated balloons diverge in clinical positioning depending on whether paclitaxel or sirolimus is used and how the coating is delivered during inflation.

Application-based distinctions further refine strategy, as coronary angioplasty procedures-encompassing both bifurcation and native coronary indications-demand different deliverability and recoil characteristics compared with neurovascular angioplasty procedures that involve extracranial or intracranial anatomy with heightened tortuosity and safety considerations. Peripheral interventions such as femoropopliteal, iliac, and renal procedures emphasize durable lesion patency and may favor drug coated approaches in specific lesion contexts. End-user segmentation across ambulatory surgical centers, clinics, and hospitals affects purchasing cycles, inventory holding patterns, and training requirements. Balloon materials-nylon, PET, and polyurethane-bring trade-offs in compliance and burst strength, while sales channels split between offline and online avenues, each with implications for customer engagement, post-sale support, and regulatory documentation. Synthesizing these dimensions supports tailored value propositions that align device attributes to clinical needs and procurement realities.

Clear-eyed regional insights that differentiate commercial approaches across the Americas, EMEA markets, and Asia-Pacific to optimize adoption, reimbursement, and supply strategies

Regional dynamics create heterogeneous demand patterns and regulatory landscapes that materially influence commercialization and clinical adoption strategies. In the Americas, advanced interventional cardiology infrastructure and broad access to tertiary care centers drive high procedural volumes and early adoption of incremental device innovations, while reimbursement frameworks and regional supply chain capabilities also shape purchasing behavior. Europe, the Middle East, and Africa exhibit considerable heterogeneity; western European markets often emphasize evidence-based adoption and rigorous procurement tenders, whereas emerging markets across the broader EMEA region prioritize cost-efficiency and scalable inventory models, resulting in differentiated go-to-market approaches.

Asia-Pacific markets present a mix of rapid clinical modernization, localized manufacturing capacity, and diverse regulatory pathways, prompting many companies to calibrate market entry strategies by country. Transitional phrases are important here because cross-border regulatory harmonization and regional manufacturing investments can change competitive dynamics quickly; companies with adaptive regulatory teams and regional commercial partners can accelerate uptake by aligning clinical evidence generation and pricing strategies to local practice patterns. Ultimately, tailoring product portfolios and engagement models to the specific needs of each region enhances both adoption and long-term clinical integration.

How innovation-focused firms are balancing R&D, clinical evidence generation, and manufacturing flexibility to secure competitive advantage and consistent clinical adoption

Leading companies in the PTA balloon catheter space are emphasizing a combination of targeted R&D investments, strategic partnerships, and manufacturing agility to sustain differentiation. Many firms are reallocating resources toward materials science and coating technologies to improve deliverability and biological interaction, while others prioritize cultivating clinical evidence through investigator-initiated studies and registry participation to substantiate claims around durability and safety. Collaboration with hospital systems and key opinion leaders remains a central tactic to validate device performance in complex anatomies and to create real-world evidence that supports adoption in both high-acuity and ambulatory settings.

At the same time, commercial strategies increasingly integrate digital tools for customer engagement, inventory analytics, and procedural training to reduce friction in purchasing and to enhance post-sale support. Several players are also pursuing manufacturing footprint optimization, either through strategic contracts with regional manufacturing partners or through selective vertical integration, to reduce lead times and improve quality control. Those that balance innovation with disciplined regulatory execution and pragmatic supply chain planning are better positioned to navigate payer scrutiny and to sustain adoption across diverse clinical and geographic contexts.

Practical, high-impact recommendations for device makers to align product strategy, evidence generation, and supply chain resilience with distinct clinical and commercial realities

Industry leaders should pursue a set of actionable initiatives to strengthen competitive positioning and to accelerate clinical uptake. First, align product development roadmaps with specific procedural niches by combining material and coating choices to address distinct lesion sets, thereby reducing clinical ambiguity in device selection. Second, invest in pragmatic clinical evidence programs that complement randomized trials with registries and real-world data to demonstrate value for diverse patient populations and care settings. Third, adopt a geographically nuanced supply strategy that blends regional manufacturing with multi-sourcing for critical inputs to mitigate tariff and logistics risk while maintaining quality oversight.

Furthermore, optimize commercial models by tailoring sales and education approaches to ambulatory surgical centers, clinics, and hospitals, recognizing that each end-user cohort has unique purchasing cycles and training needs. Enhance digital engagement and e-commerce readiness to support online sales channels while preserving the high-touch relationships that drive complex device adoption. Finally, seek strategic partnerships for coating technology, distribution, or post-market surveillance to accelerate time-to-clinic and to share development risk, ensuring that each initiative has clear metrics and accountable owners to track progress and impact.

Transparent mixed-methods research design combining secondary synthesis and primary expert validation to ensure rigorous, reproducible insights and clear limitations

This research applied an integrated methodology that combined structured secondary intelligence with primary qualitative validation to create a robust, reproducible evidence base. Secondary analysis synthesized peer-reviewed clinical literature, regulatory filings, material science publications, and procedural guidelines to map device classes, use cases, and known safety considerations. Building on that foundation, primary research included semi-structured interviews with interventional clinicians, procurement professionals, and device development leaders to validate market dynamics, to probe adoption barriers, and to surface operational nuances across different care settings.

Data triangulation procedures reconciled findings across sources and ensured consistency between clinical insights and commercial realities. Segmentation logic was applied to align product, application, end-user, material, and sales channel dimensions, and regional analysis considered regulatory pathways and supply chain configurations. Limitations included variability in publicly available proprietary data and the evolving nature of post-market evidence, factors that were mitigated by prioritizing contemporary primary interviews and cross-validation with multiple expert respondents. The methodological approach emphasizes transparency, traceability, and adaptability to future updates.

Concluding synthesis linking device innovation, clinical strategy, and operational resilience to actionable imperatives for sustained clinical adoption and commercial success

In conclusion, the PTA balloon catheter domain is at an inflection point where clinical nuance, material innovation, and supply chain strategy intersect to create differentiated opportunities for device manufacturers, clinicians, and payers. Device selection is becoming more lesion-specific and evidence-driven, prompting companies to match product engineering with clear clinical use cases while sustaining robust post-market surveillance. Trade policy volatility and tariff adjustments add an additional layer of operational complexity, encouraging greater emphasis on localized manufacturing and resilient sourcing strategies.

Ultimately, organizations that integrate targeted R&D, pragmatic evidence generation, and flexible commercial models will be best positioned to translate technological advances into sustained clinical adoption. The interplay between product design, clinical application, end-user environment, material choice, and distribution channel underscores the importance of a holistic strategy that anticipates regulatory, reimbursement, and supply chain contingencies while delivering demonstrable clinical value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PTA Balloon Catheter Market, by Product Type

  • 8.1. Conventional Balloon
    • 8.1.1. Compliant
    • 8.1.2. Non-Compliant
    • 8.1.3. Semi-Compliant
  • 8.2. Cutting Balloon
  • 8.3. Drug Coated Balloon
    • 8.3.1. Paclitaxel Coated
    • 8.3.2. Sirolimus Coated

9. PTA Balloon Catheter Market, by Balloon Material

  • 9.1. Nylon
  • 9.2. PET
  • 9.3. Polyurethane

10. PTA Balloon Catheter Market, by Application

  • 10.1. Coronary Angioplasty
    • 10.1.1. Bifurcation
    • 10.1.2. Native Coronary
  • 10.2. Neurovascular Angioplasty
    • 10.2.1. Extracranial
    • 10.2.2. Intracranial
  • 10.3. Peripheral Angioplasty
    • 10.3.1. Femoropopliteal
    • 10.3.2. Iliac
    • 10.3.3. Renal

11. PTA Balloon Catheter Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. PTA Balloon Catheter Market, by Sales Channel

  • 12.1. Offline
  • 12.2. Online

13. PTA Balloon Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PTA Balloon Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PTA Balloon Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States PTA Balloon Catheter Market

17. China PTA Balloon Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Accura Medizintechnik GmbH
  • 18.7. Andratec GmbH
  • 18.8. AV Medical Technologies Ltd.
  • 18.9. B. Braun SE
  • 18.10. Becton, Dickinson and Company
  • 18.11. Biosensors International Group, Ltd.
  • 18.12. BIOTRONIK SE & Co. KG
  • 18.13. Boston Scientific Corporation
  • 18.14. BrosMed Medical Co., Ltd
  • 18.15. Cardinal Health, Inc.
  • 18.16. Conic Vascular
  • 18.17. Cook Medical Inc.
  • 18.18. Freudenberg & Co. KG
  • 18.19. Infinity Angioplasty Balloon Company
  • 18.20. Koninklijke Philips N.V.
  • 18.21. Leo Medical Co.,Ltd.
  • 18.22. Medcaptain Medical Technology Co., Ltd.
  • 18.23. Medtronic PLC
  • 18.24. Meril Life Sciences Pvt. Ltd.
  • 18.25. MicroPort Scientific Corporation
  • 18.26. Nordson Corporation
  • 18.27. NuMED
  • 18.28. Poba Medical
  • 18.29. Q3 Medical Devices Limited
  • 18.30. QX Medical LLC
  • 18.31. Ridgeback Technologies
  • 18.32. Simeks Medical
  • 18.33. Teleflex Incorporated
  • 18.34. Terumo Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PTA BALLOON CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PTA BALLOON CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COMPLIANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COMPLIANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COMPLIANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NON-COMPLIANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NON-COMPLIANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NON-COMPLIANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SEMI-COMPLIANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SEMI-COMPLIANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SEMI-COMPLIANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CUTTING BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CUTTING BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CUTTING BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PACLITAXEL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PACLITAXEL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PACLITAXEL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SIROLIMUS COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SIROLIMUS COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SIROLIMUS COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BIFURCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BIFURCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BIFURCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NATIVE CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NATIVE CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NATIVE CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY EXTRACRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY EXTRACRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY FEMOROPOPLITEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY FEMOROPOPLITEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY FEMOROPOPLITEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ILIAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ILIAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ILIAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY RENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY RENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY RENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)